Sidney Kimmel Comprehensive Cancer Center At Thomas Jefferson University
Clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center At Thomas Jefferson University, explained in plain language.
-
New combo therapy for eye cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of precise radiation therapy and an eye injection drug (aflibercept) for people with uveal melanoma, a rare eye cancer. The goal was to see if this approach could control the tumor while reducing damage to healthy eye tissue. Only 3 people enrolled…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 09:08 UTC
-
Lung cancer combo therapy trial stopped early
Disease control TerminatedThis study tested giving nivolumab (an immunotherapy) along with chemotherapy before surgery for early-stage non-small cell lung cancer. The goal was to see if this combination could shrink tumors more effectively before removal. The trial was terminated early and enrolled only 1…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Promising combo for Hard-to-Treat prostate cancer hits roadblock
Disease control TerminatedThis study looked at adding a drug called ribociclib to standard hormone therapy (enzalutamide) for men with advanced prostate cancer that had spread and stopped responding to hormone treatment. The goal was to find a safe dose and see if the combination could lower PSA levels. T…
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Common diabetes and antibiotic drugs tested against cancer, but study stopped early
Disease control TerminatedThis study tested whether combining metformin (a diabetes drug) with doxycycline (an antibiotic) could help treat localized breast or uterine cancer. It involved 29 adults who were scheduled for surgery. The goal was to see if the drugs could change certain markers in the tumor's…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Cancer-Fighting combo falls short: early trial halted
Disease control TerminatedThis study tested whether metformin (a diabetes drug) and doxycycline (an antibiotic) could help treat head and neck cancer when taken before surgery. Only 7 people enrolled before the study was stopped early. The main goal was to see changes in cancer-related proteins, not to cu…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Common diabetes drug tested to protect against radiation side effects in thyroid cancer
Symptom relief TerminatedThis small pilot study looked at whether metformin, a common diabetes medicine, could reduce side effects like dry mouth and taste changes caused by radioactive iodine treatment in people with thyroid cancer. The study planned to enroll 13 participants but was terminated early. T…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC